Switch to:
Myriad Genetics Inc (NAS:MYGN)
EV/EBIT
9.12 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Myriad Genetics Inc's enterprise value is $2,557.7 Mil. Myriad Genetics Inc's operating income for the trailing twelve months (TTM) ended in Mar. 2014 was $287.1 Mil. Therefore, Myriad Genetics Inc's EV/EBIT ratio for today is 9.12.

MYGN' s 10-Year EV/EBIT Range
Min: 4.4   Max: 52.4
Current: 9.12

4.4
52.4

During the past 13 years, the highest EV/EBIT Ratio of Myriad Genetics Inc was 52.40. The lowest was 4.40. And the median was 10.20.

MYGN's EV/EBITis ranked higher than
95% of the 198 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 9999.00 vs. MYGN: 9.12 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Myriad Genetics Inc's enterprise value for the quarter that ended in Mar. 2014 was $2,282.7 Mil. Myriad Genetics Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was $287.1 Mil. Myriad Genetics Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2014 was 12.58%.


Definition

Myriad Genetics Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=2557.695/287.106
=8.91

Myriad Genetics Inc's current Enterprise Value is $2,557.7 Mil.
Myriad Genetics Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was 65.916 (Jun. 2013 ) + 82.904 (Sep. 2013 ) + 82.999 (Dec. 2013 ) + 55.287 (Mar. 2014 ) = $287.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Myriad Genetics Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Mar. 2014 )=Operating Income (TTM)/Enterprise Value (Q: Mar. 2014 )
=287.106/2282.6863
=12.58 %

Myriad Genetics Inc's Enterprise Value for the quarter that ended in Mar. 2014 was $2,282.7 Mil.
Myriad Genetics Inc's Operating Income for the trailing twelve months (TTM) ended in Mar. 2014 was 65.916 (Jun. 2013 ) + 82.904 (Sep. 2013 ) + 82.999 (Dec. 2013 ) + 55.287 (Mar. 2014 ) = $287.1 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Myriad Genetics Inc Annual Data

Jun04Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13
ev2ebit 0.000.000.000.0026.1226.657.4210.229.007.86

Myriad Genetics Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
ev2ebit 8.299.519.009.849.408.087.865.854.147.95
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide